Nektar Therapeutics (NKTR:NASDAQ) soared at $26.92, a gain of 24.7%. The stock got featured on our News Catalysts scanner on Fri 10 Jan 20 at 03:59 PM in the 'INVESTOR UPDATE' category. From Wed 18 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Nektar Therapeutics (NKTR:NASDAQ)
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%